2020 BPS Board of Directors Call for Nominations

Three Positions Available

 

Washington, DC – The Board of Pharmacy Specialties (BPS) is seeking nominations for individuals to serve on its Board of Directors. The term of appointment for BPS Board members is based on the calendar year. Each appointment is for three years with the possibility of re-appointment to a second 3-year term. The specific term for this call is January 1, 2020 to December 31, 2022. 

 

Important Dates

BPS must receive the following nomination materials NO LATER THAN Wednesday, August 7, 2019:

  1. Completed and signed Nomination Form https://fs24.formsite.com/BPSforms/form3/index.html
  2. Candidate Statement of Interest (300 words or less) responding to the prompt: “Why are you interested in serving as a member of the BPS Board of Directors?”
  3. Current resumé or curriculum vitae
  4. Completed and signed Disclosure and Antitrust Statement
  5. Up to two letters of recommendation (optional)

 

For more information on guidelines for appointment, responsibilities/duties, and the conflict of interest policies, and antitrust and disclosure statement forms, please refer to the BPS Board of Directors Call for Nominations Booklet.

 

The appointments will be announced on or about Wednesday, September 18, 2019.

 

New Board members will be asked to attend Fall Board Meeting as observers in Alexandria, VA on October 4-6, 2019, and participate in a BPS orientation webinar or onsite meeting in February 2020.

 

SPECIFIC INFORMATION

OPEN POSITIONS FOR the 2020-2022 TERM

 

The Board of Pharmacy Specialties Constitution and Bylaws states the following:

The Board of Pharmacy Specialties shall be composed of twelve (12) voting members who shall be appointed by the Board of Pharmacy Specialties. The membership shall be composed of:

 

– Three (3) public members, at least one (1) of whom shall meet the current criteria established by the National Commission for Certifying Agencies (NCCA) for public members. Other public members may be non-pharmacist health professionals;

– Nine (9) pharmacist members, three (3) of whom are pharmacists who are not Board-certified, and six (6) of whom are pharmacists who are Board-certified in different, unique, recognized pharmacy specialties.

The Board-certified pharmacist members shall be in one of each of the six (6) specialties recognized by the Board of Pharmacy Specialties, and in the event that there are greater than six (6) specialties, a rotation will be established to ensure a balance of specialty program input. The Board of Pharmacy Specialties shall seek nominations from the appropriate community of interest for each of the pharmacist slots on the Board. The Board members represent the best interests of the Board of Pharmacy Specialties and not an individual organization.

 

The Board of Pharmacy Specialties (BPS) is currently seeking nominees for three positions on BPS Board of Directors. The open Board of Directors seats for 2020 are listed below.

 

Non-Pharmacist Health Professional Member (One Opening for 2020)

This position on the BPS Board shall be filled by a non-pharmacist health professional. Current Board Member, Marie E. Michnich, DrPH, Senior Scholar at the National Academy of Medicine, will be completing an unexpired term and is eligible for re-appointment.

 

At-Large Pharmacist Member (One Opening for 2020)

This pharmacist position on the BPS Board shall be filled by a pharmacist who is not Board-certified. Current At-Large Member, William Evans, PharmD, faculty member at St. Jude Children’s Research Hospital is completing his second term and is not eligible for reappointment.

 

Board-Certified Pharmacist Member (One Opening for 2020)

Six pharmacist positions on the BPS Board of Directors shall be held by pharmacists currently certified in the different specialties recognized by BPS. The 2020 opening on the BPS Board of Directors are from one of the following Board-Certified Pharmacy Specialties: Board-Certified Cardiology Pharmacist (BCCP), Board-Certified Critical Care Pharmacist (BCCCP), Board-Certified Infectious Diseases Pharmacist (BCIDP), Board-Certified Nuclear Pharmacist (BCNP), Board-Certified Oncology Pharmacist (BCOP), or Board-Certified Pediatric Pharmacy Specialist (BCPPS).

 

Current Board Member, Andrea A. Iannucci, PharmD, BCOP, from the University of California, Davis Medical Center is completing her second term and is not eligible for reappointment.

 

About the Board of Pharmacy Specialties

The Board of Pharmacy Specialties (BPS) was established in 1976 as an autonomous division of the American Pharmacists Association (APhA). The mission of BPS is to improve patient care by positioning BPS Board-Certified Pharmacist Specialists as integral members of multidisciplinary healthcare teams, through recognition and promotion of specialized training, knowledge, and skills for pharmacists in the United States and internationally. Board certification is a recognized credential for determining which pharmacists are qualified to contribute at advanced practice levels given the rigorous standards mandated by BPS board certification and recertification. BPS currently recognizes more than 41,000 pharmacist certifications across 11 specialties.

 

###

BPS Contact

Alexander Jean-Baptiste

Social Media & Content Marketing Manager

AJeanbaptiste@aphanet.org

(202) 760-3836